This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

Malaria Diagnostics

Our work in malaria diagnostics

PATH works to ensure that diagnostic tools to improve malaria case management and contribute to elimination are available and accessible to malaria endemic populations. We collaborate with partners to develop, evaluate, and commercialize highly sensitive tests to detect low-density infections and point-of-care tests for G6PD deficiency to guide treatment of patients with Plasmodium vivax. PATH makes available biological materials for test developers and materials to support implementation of diagnostic testing, as well as market and technology landscapes of malaria diagnostics.

Below are resources developed for our partners. New resources are added on a regular basis. If you do not see the resource you are looking for, please contact